6 unchanged sentences
Specimen Common Stock Certificate
−Removed: Separation Agreement, dated January 30, 2025, by and between CytomX Therapeutics, Inc.
−Removed: and Jeffrey Landau.
+Added: Amended and Restated CytomXTherapeutics, Inc.
+Added: 2015 Equity Incentive Plan.
+Added: Amended and Restated CytomX Therapeutics, Inc.
+Added: Employee Stock Purchase Plan.
Certification of Chief Executive Principal required by Rule 13a-14(a) or Rule 15d-14(a).
9 unchanged sentences
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
+Added: # Indicates management contract or compensatory plan
* The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of CytomX Therapeutics, Inc.
2 unchanged sentences
CytomX Therapeutics, Inc.
+Added: August 7, 2025
Chief Executive Officer and Chairman
(Principal Executive Officer)
+Added: August 7, 2025
/s/ Christopher W.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.